Already having claimed the lives of over 40 million people globally, at the end of 2022, reports suggest that 39 million people were still living with HIV/Aids, with South Africa having the largest percentage worldwide.
Lessons from the COVID-19 pandemic have underlined the importance of continued investment into pharmaceutical innovation and R&D to not only bring life-saving medications to those in need, but to improve public health outcomes
The World Health Organization (WHO) defines health as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.”